Medication-Assisted Treatment (MAT) Waiver Training
Monday, June 28th and Wednesday, June 30th
1:00pm - 5:00pm both days, remotely via Zoom Meetings.
To prescribe buprenorphine, one of three medications approved by the FDA for the treatment of opioid use disorder, physicians are required to complete 8 hours of training in order to apply to the Drug Enforcement Agency for a waiver.
This two part free course will provide prescribers with the 8 hours of required MAT training.
Following completion of the course, attendees will be given a link to complete the remainder of the training at no cost from the Providers Clinical Support System (PCSS).
Nurse Practitioners (NP) and Physician assistants (PA) are required to complete 24 hours of training including the 8 hour MAT training.
At the conclusion of this activity participants should be able to:
• Screen and identify patients with OUD and define evidence-based treatments.
• Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
• Describe the fundamentals of office-based opioid treatment including the treatment of the
• Explain the process of buprenorphine induction as well as stabilization and maintenance.
• Discuss all FDA approved antagonist and agonist medications to treat OUD.
• Discuss basic office protocols including medical record documentation and confidentially.
• Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
• Recognize the importance of obtaining a waiver to begin treating patients with OUD.
This event has been approved by the Office of Continuing Medical Education and has been awarded a maximum of 8 AMA PRA Category 1 Credit(s). Please contact firstname.lastname@example.org
with any questions.
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by the American Academy of Addiction Psychiatry, Arizona State University, The Arizona Chapter of the American Society of Addiction Medicine, and Arizona Health Care Cost Containment System. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Designation Statement: American Academy of Addiction Psychiatry designates this live course for a maximum of 8 (eight) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Designation Statement: American Academy of Addiction Psychiatry is an approved provider of nursing continuing education through AAAP’s Joint Accreditation provider # 4008192. This program is approved for up to 8 Nursing Contact Hours.
PA Designation Statement:
American Academy of Addiction Psychiatry has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
American Academy of Addiction Psychiatry is the Data Sponsor for this training. Funding for this course was made possible (in part) by 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Additional Funding Attribution: Arizona State Opioid Response (SOR) grant, Arizona Health Care Cost Containment System, Substance Abuse and Mental Health Services Administration, grant #T1081709-01.